{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:44:15Z","timestamp":1790307855418,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194325","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T17:56:44Z","timestamp":1522259804000},"page":"e0194325","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-1690","authenticated-orcid":true,"given":"Chad K.","family":"Porter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Lynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawsar","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro L.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"DeNearing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Feijoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth D.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Louis","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"issue":"49","key":"ref1","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1016\/j.vaccine.2017.07.036","article-title":"Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques","volume":"35","author":"KL Kotloff","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.2009.80.609","article-title":"Global etiology of travelers&apos; diarrhea: systematic review from 1973 to the present","volume":"80","author":"N Shah","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4269\/ajtmh.2006.74.891","article-title":"Incidence, etiology, and impact of diarrhea among long-term travelers (U.S. military and similar populations): A systematic review","volume":"74","author":"MS Riddle","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"S2","key":"ref4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7205\/MILMED-D-17-00064","article-title":"Travelers&apos; Diarrhea: An Update on the Incidence, Etiology, and Risk in Military Deployments and Similar Travel Populations","volume":"182","author":"CK Porter","year":"2017","journal-title":"Mil Med"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4269\/ajtmh.2006.74.891","article-title":"Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review","volume":"74","author":"MS Riddle","year":"2006","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"8","key":"ref6","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"KL Kotloff","year":"1999","journal-title":"Bulletin of the World Health Organization"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S0950268812001677","article-title":"The <italic>Shigella<\/italic> human challenge model","volume":"141","author":"CK Porter","year":"2012","journal-title":"Epidemiology and Infection"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(17)30276-1","article-title":"Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"49","key":"ref9","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1016\/j.vaccine.2017.05.035","article-title":"Chronic consequences on human health induced by microbial pathogens: Growth faltering among children in developing countries","volume":"35","author":"JP Nataro","year":"2017","journal-title":"Vaccine"},{"issue":"7620","key":"ref10","first-page":"583","article-title":"Turista in Teheran. Travellers&apos; diarrhoea at the Eighth International Congresses of Tropical Medicine and Malaria","volume":"2","author":"BH Kean","year":"1969","journal-title":"Lancet"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13104-016-2236-7","article-title":"A review on Sero diversity and antimicrobial resistance patterns of Shigella species in Africa, Asia and South America, 2001\u20132014","volume":"9","author":"AG Kahsay","year":"2016","journal-title":"BMC research notes"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2458-13-S3-S11","article-title":"Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus","volume":"13","author":"JK Das","year":"2013","journal-title":"BMC public health"},{"key":"ref13","article-title":"Committee WHOPDfVA. Report from the World Health Organization&apos;s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016","author":"BK Giersing","year":"2017","journal-title":"Vaccine"},{"key":"ref14","article-title":"Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy","author":"D Hosangadi","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"e0149358","DOI":"10.1371\/journal.pone.0149358","article-title":"An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli","volume":"11","author":"CK Porter","year":"2016","journal-title":"PloS one"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1191\/1740774505cn087oa","article-title":"Meta-analysis of individual patient data from randomized trials: a review of methods used in practice","volume":"2","author":"MC Simmonds","year":"2005","journal-title":"Clinical trials (London, England)"},{"key":"ref17","article-title":"Theory and Applications of Correspondence Analysis","author":"MJ Greenacre","year":"1984"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0264-410X(94)00011-B","article-title":"Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2","volume":"13","author":"KL Kotloff","year":"1995","journal-title":"Vaccine"},{"key":"ref19","article-title":"Flexyn2a, a candidate bioconjugate vaccine against Shigella flexneri 2a induces protective immune response in a controlled human infection model","author":"KR Talaat","year":"2017","journal-title":"Vaccines for Enteric Diseases"},{"issue":"S2","key":"ref20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7205\/MILMED-D-17-00077","article-title":"Management of Acute Diarrheal Illness During Deployment: A Deployment Health Guideline and Expert Panel Report","volume":"182","author":"MS Riddle","year":"2017","journal-title":"Mil Med"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pst.331","article-title":"Consequences of dichotomization","volume":"8","author":"V Fedorov","year":"2009","journal-title":"Pharm Stat"},{"key":"ref22","article-title":"Development of a S. sonnei controlled human infection model using a lyophilized GMP lot of strain 53G","author":"RW Frenck Jr.","year":"2017","journal-title":"Vaccines for Enteric Diseases"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/125.1.12","article-title":"Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection","volume":"125","author":"HL DuPont","year":"1972","journal-title":"Journal of Infectious Disease"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0264-410X(95)00102-7","article-title":"A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity","volume":"13","author":"KL Kotloff","year":"1995","journal-title":"Vaccine"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0264-410X(90)90094-3","article-title":"Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease","volume":"8","author":"DA Herrington","year":"1990","journal-title":"Vaccine"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/503039","article-title":"Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge","volume":"42","author":"DN Taylor","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4269\/ajtmh.1992.47.276","article-title":"Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge","volume":"47","author":"CO Tacket","year":"1992","journal-title":"American Journal of Tropical Medicine and Hygeine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jama.1946.02870420002002","article-title":"Experimental human bacillary dysentery; polyvalent dysentery vaccine in its prevention","volume":"132","author":"HJ Shaughnessy","year":"1946","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"TS Coster","year":"1999","journal-title":"Infection and Immunity"},{"key":"ref30","unstructured":"Durbin AP, Bourgeois AL, McKenzie R, Moulton L, Mallett CP, Harrington J, et al., editors. Intranasal Immunization with Proteosome-Shigella flexneri 2A LPS Vaccine: Factors Associated with Protection in a Volunteer Challenge Model. Infectious Diseases Society of America 39th Annual Meeting; 2001 October 27, 2001; San Francisco."},{"key":"ref31","unstructured":"Harro C, Riddle MS, Kaminski RW, Turbyfill KR, Gormley R, Porter CK, et al., editors. Shigella flexneri 2a Invaplex 50 intranasal vaccine phase 2b challenge study. 5th International Vaccines for Enteric Diseases Conference; 2009; Malaga, Spain."},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CVI.00665-15","article-title":"Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults","volume":"23","author":"P Pitisuttithum","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1128\/AAC.01108-07","article-title":"Systemic pharmacokinetics of rifaximin in volunteers with shigellosis","volume":"52","author":"DN Taylor","year":"2008","journal-title":"Antimicrobial agents and chemotherapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T11:12:25Z","timestamp":1604056345000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194325"}},"subtitle":[],"editor":[{"given":"Nicholas J.","family":"Mantis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194325","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]}}}